Journal
EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 18, Issue 7, Pages 508-518Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.euroneuro.2008.02.006
Keywords
ghrelin; nicotinic acetylcholine; receptors; reward systems
Ask authors/readers for more resources
Previously, we have reported that the orexigenic peptide ghrelin activates the cholinergic-dopaminergic reward [ink, involving nicotinic acetylcholine receptors (nAChR). The alpha(3)-alpha(7) and beta(2)-beta(4) subunits of the nAChR can be combined into pentameric nAChRs, with different functional roles. The present experiments show that the locomotor stimulatory effects of ghrelin, either into laterodorsal tegmental area (LDTg) or ventral tegmental area (VTA), are mediated via ventral tegmental nAChR, but neither the alpha(4)beta(2)* (using dihydro-beta-erythroidine) nor the alpha(7)* (using methyllycaconitine) subtypes appears to be involved. On the other hand, the alpha(3)beta(2)*, beta(3)*, and/or alpha(6)* (using a.-conotoxin MII) subtypes in the VTA mediate the stimulatory and DA-enhancing effects of ghrelin, a pattern that ghrelin shares with ethanol (n= 5-8). Radioligand-binding experiments shown that ghrelin does not interfere directly with nAChRs (n=26). We therefore suggest that the alpha(3)beta(2)*, beta* and/or alpha(6)* subtypes might be pharmacological targets for treatment of addictive behaviours; including compulsive overeating and alcoholism. (c) 2008 Elsevier B.V. and ECNP. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available